Apple, Corcept, HP, Transocean: U.S. Stock Market Preview

Shares of the following companies may have unusual moves in U.S. trading.

Apple Inc. (AAPL US): HTC Corp. lost a patent-infringement claim against the world’s largest technology company at the U.S. International Trade Commission, the first of the Taiwanese handset maker’s cases targeting the iPhone.

Codexis Inc. (CDXS US): Alan Shaw resigned as president and chief executive officer of the company, which makes enzymes used in producing drugs. He will continue to serve as an adviser to the board. The board appointed Peter Strumph, business head of pharmaceuticals, as interim CEO.

Corcept Therapeutics Inc. (CORT US): The specialty drug company that hasn’t generated revenue since 2009 won approval for its leading product candidate, a treatment that uses the active ingredient of the abortion pill RU-486 to treat Cushing’s Syndrome.

Corning Inc. (GLW US): The largest maker of glass for flat-panel television sets is poised to rebound to $20 in two to three years as it cuts excess capacity and focuses on the growing smartphone and tablet markets, Barron’s reported in its “The Trader” column, citing Alan Lancz of Alan B. Lancz & Associates.

Experian Plc (EXPGY US): Experian’s U.S.-traded shares are poised to rise 20 percent or more during the next year as the credit-report provider’s expansion in Latin America boosts earnings, Barron’s reported.

Hewlett-Packard Co. (HPQ US): The outlook for the world’s largest personal computer maker is still unclear as Chief Executive Officer Meg Whitman tries to turn it around by changing the corporate culture and boosting research and development expenditure, Barron’s reported.

Transocean Ltd. (RIG US): The world’s biggest operator of offshore drilling rigs said it won’t recommend a dividend payment at its 2012 annual shareholder meeting.

Wynn Resorts Ltd. (WYNN US): Japanese billionaire Kazuo Okada’s Universal Entertainment Corp. (6425 JP) said it will take legal action after Wynn Resorts, a casino operator, forcibly redeemed Universal’s stake at a 31 percent discount and accused Okada of improper payments.

Before it's here, it's on the Bloomberg Terminal. LEARN MORE